Our Products

We enhance infectious disease diagnostics through advanced technology, offering multiplex detection methods, heightened sensitivity, real-time analysis, and portable point-of-care testing.

Multiplex detection techniques

Advanced microfluidics

The Portable Multiplex Malaria Detection Device

The Portable Multiplex Malaria Detection Device is a cutting-edge diagnostic tool designed to revolutionize malaria diagnosis, especially in resource-constrained and remote regions of the developing world. This device utilises advanced microfluidics and multiplex detection techniques to rapidly and accurately detect malaria parasites in patient samples. 

Its portability and user-friendly design make it suitable for use in settings with limited access to sophisticated laboratory infrastructure and trained personnel. By providing timely and accurate diagnosis, the device enables healthcare providers to initiate prompt treatment, thereby reducing the morbidity and mortality associated with malaria. In essence, it represents a critical advancement in global health, addressing a pressing need for accessible and effective diagnostic tools in regions where malaria is endemic.

  • Cutting-edge diagnostic tool designed to revolutionize malaria diagnosis in resource-constrained regions.
  • Utilizes advanced microfluidics and multiplex detection techniques for rapid and accurate detection of malaria parasites.
  • Portable design enables use in settings with limited access to sophisticated laboratory infrastructure.
  • User-friendly interface allows healthcare providers to perform testing even without extensive training.
  • Enables prompt diagnosis and treatment initiation, reducing morbidity and mortality associated with malaria.
  • Represents a critical advancement in global health, addressing the pressing need for accessible and effective diagnostic tools in malaria-endemic regions.

Rapid Point-of-Care Testing

User-Friendly Design

Crimean-Congo Haemorrhagic Fever (CCHF) Rapid Test

The CCHF Rapid Test represents a groundbreaking advancement in the field of disease diagnosis, specifically targeting Crimean-Congo Haemorrhagic Fever (CCHF). This innovative test is designed to provide rapid, point-of-care diagnostic capabilities, addressing the critical challenge of timely and accurate diagnosis in resource-limited settings.

Key Features and Importance:

  1. Rapid Point-of-Care Testing: The CCHF Rapid Test offers rapid diagnostic capabilities, enabling healthcare providers to quickly identify CCHF cases at the point of care. This timely diagnosis is crucial for initiating appropriate treatment and implementing control measures to prevent further transmission.

  2. User-Friendly Design: The test is designed to be user-friendly, allowing healthcare workers with minimal training to perform the test accurately. This feature is essential for deploying the test effectively in remote and resource-limited areas where access to skilled laboratory personnel may be limited.

  3. Minimal Infrastructure Requirements: The CCHF Rapid Test operates with minimal infrastructure, making it suitable for deployment in settings with limited laboratory facilities or electricity. This portability and ease of use enhance the accessibility of diagnostic testing in areas where traditional laboratory-based testing may not be feasible.

  4. Resilience to Environmental Conditions: The test is engineered to withstand diverse environmental conditions, ensuring its reliability and performance even in challenging settings. This resilience makes the test well-suited for use in regions where environmental factors, such as temperature and humidity, may vary significantly.

  5. Timely Results: The CCHF Rapid Test provides results within minutes to hours, allowing for prompt decision-making by healthcare providers and public health authorities. This rapid turnaround time is critical for implementing appropriate patient management strategies and outbreak response measures.